<div id="readability-page-1">Looking for top-rated stocks to buy now? Recent analyst updates highlight three companies that have earned Strong Buy ratings from Top Wall Street analysts. Each stock offers solid upside potential, supported by fresh Buy calls.<h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. </li><li> Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off </li></ul> For more stock ideas, check out TipRanks' Analyst Top Stocks tool, which tracks the latest Buy ratings from top analysts in real time. Here are today's top analyst-backed stock picks. Click on any ticker to research the company before deciding whether to add it to your portfolio. <ul> <li>Disc Medicine (IRON) – Disc Medicine is a clinical-stage biotech company developing treatments for blood and iron-related disorders. Today, Morgan Stanley analyst Sean Laaman maintained a Buy rating on the stock with a price target of $115 per share. In the last three months, all 12 Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 23.21%. </li> <li>Bicara Therapeutics Inc. (BCAX) – Bicara is a biotech company focused on developing antibody-based therapies for cancer. Today, H.C. Wainwright analyst Robert Burns maintained a Buy rating on the stock with a price target of $40 per share. Interestingly, five out of the six Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 87.91%. </li> <li>HASI (HASI) – HASI is a renewable energy finance company that invests in clean energy and climate-focused infrastructure projects. Today, J.P. Morgan analyst Mark Strouse maintained a Buy rating on the stock with a price target of $45 per share. Interestingly, nine out of the 11 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 23.67%.</li> </ul> <h2>Who Are the Top Analysts? </h2> TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks' Top Wall Street Analysts page. </div>

IRON

Top analysts have given 'Strong Buy' ratings to three stocks: Disc Medicine (IRON), Bicara Therapeutics Inc. (BCAX), and HASI. Disc Medicine has a price target of $115, implying a 23.21% upside. Bicara Therapeutics has a target of $40, with an 87.91% upside. HASI has a target of $45, suggesting a 23.67% upside. TipRanks offers tools for tracking analyst ratings and insights.

3 'Strong Buy' Stocks to Buy Today, 12/8/2025, According to Top Analysts